CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 172,380 | ||
| 2023-01-25 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +54,000 | 138,424 | ||
| 2023-01-25 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (right to buy) | +76,200 | 76,200 | ||
| 2023-01-25 | Hull Hans Chief Business Officer | Grant or award | +54,000 | 192,191 | ||
| 2023-01-25 | Hull Hans Chief Business Officer | Grant or award · Stock Option (right to buy) | +76,200 | 76,200 | ||
| 2023-01-25 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +39,000 | 44,947 | ||
| 2023-01-25 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2023-01-25 | Lefebvre Eric Chief Medical Officer | Grant or award | +57,000 | 133,926 | ||
| 2023-01-25 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-01-25 | Coulie Bernard President and CEO | Grant or award | +146,300 | 240,112 | ||
| 2023-01-25 | Coulie Bernard President and CEO | Grant or award · Stock Option (right to buy) | +206,300 | 206,300 | ||
| 2023-01-25 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 108,812 |
| 2023-01-25 | Coulie Bernard President and CEO | Sale | −13,304 | $32.40 | $431K | 95,508 |
| 2023-01-25 | Coulie Bernard President and CEO | Sale | −1,696 | $33.29 | $56K | 93,812 |
| 2023-01-25 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 202,380 | ||
| 2023-01-24 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 108,812 |
| 2023-01-24 | Coulie Bernard President and CEO | Sale | −15,000 | $30.89 | $463K | 93,812 |
| 2023-01-24 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 217,380 | ||
| 2023-01-23 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 108,812 |
| 2023-01-23 | Coulie Bernard President and CEO | Sale | −10,150 | $33.71 | $342K | 98,662 |
Page 11 of 19 · 379 trades